Skip to main content

Table 5 Common toxicity criteria among all patients after neoadjuvant chemotherapy

From: Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial

Variable Chemotherapy toxicity
  N %
Fatigue 40 88.9
Alopecia 38 84.4
Arthralgia and myalgia 8 17.8
Diarrhoea 5 11.1
Mouth sores 4 8.9
Febrile neutropenia 3 6.7